National Cancer Centre Singapore

Recent papers from National Cancer Centre Singapore

1. Development of Preference Weights for the 10-item Singapore Caregiver Quality Of Life Scale: A Discrete Choice Experiment2026
2. Real-world treatment patterns and clinical outcomes in relapsed/refractory multiple myeloma across Asia: a multicenter Asian Myeloma Network study (AMN010)Blood Cancer Journal · 2026
3. Treatment of Recurrent and/or Metastatic Nasopharyngeal Carcinoma: CSCO and ASCO Joint GuidelineJournal of Clinical Oncology · 2026
4. Treatment of Stage IB to III Nasopharyngeal Carcinoma: CSCO-ASCO Guideline UpdateJournal of Clinical Oncology · 2026
5. Pre‐emptive pharmacogenomics testing in clinical practice: A pilot implementation in SingaporeBritish Journal of Clinical Pharmacology · 2026
6. Acquired resistance to vorinostat in cutaneous T cell lymphoma involves augmented ERK phosphorylationCommunications Biology · 2026
7. IL1B⁺ Tumor-associated macrophages arise from inflammatory cancer-associated fibroblasts niches and are correlated with head and neck squamous cell carcinoma recurrencenpj Precision Oncology · 2026
8. Navigating the Role of Clinical Pharmacists in Integrative Oncology Care Teams: Time to Create Higher Training and Practice StandardsClinical Pharmacology & Therapeutics · 2026
9. Multiple standards of care in non-small-cell lung cancer after EGFR-TKI therapy: progress, fragmentation, or inevitability?The Lancet · 2026
10. Energy-Transducing Scintillating Nanoparticles for Combined Proton Beam Therapy and Photodynamic TherapyACS Applied Nano Materials · 2026
11. Comparative Age-Period-Cohort Analysis Reveals Divergent Temporal Trajectories of Breast and Colorectal Cancer Among Women in SingaporeCancers · 2026
12. Age-specific income losses due to HPV-attributable cancers in SingaporePLoS ONE · 2026
13. RankMap: rank-based reference mapping for fast and robust cell type annotation in spatial and single-cell transcriptomicsBMC Bioinformatics · 2026
14. Implications of non-compliance in the experimental arm on treatment effect estimation in randomised controlled trials: a methodological assessment of four summary measuresBMC Medical Research Methodology · 2026
15. Polygenic and classical risk integration reshapes breast cancer screening recommendations in 9,761 Asian womenBMC Medicine · 2026
16. A clinical multimodal vision language foundation model with fine-grain explainabilityNature Medicine · 2026
17. Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with early and locally advanced non-small-cell lung cancerESMO Open · 2026
18. Germline PALB2-mutated triple negative breast cancer treated with Olaparib in a kidney transplant patientJournal of Clinical Question · 2026
19. Changing sarcopenia diagnostic criteria from AWGS2019 to 2025 impacts prevalence and postoperative risk predictionCommunications Medicine · 2026
20. Identifying adults with serious illness in Singapore’s surgical population and its impact on postoperative healthcare utilisation and costsAnnals of the Academy of Medicine Singapore · 2026